- Home
- OGEN vs SINT Comparison
OGEN vs SINT Comparison
Compare OGEN & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- SINT
- Stock Information
- Founded
- OGEN 1996
- SINT 1996
- Country
- OGEN United States
- SINT United States
- Employees
- OGEN N/A
- SINT N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- OGEN Health Care
- SINT Health Care
- Exchange
- OGEN Nasdaq
- SINT Nasdaq
- Market Cap
- OGEN 3.9M
- SINT 4.4M
- IPO Year
- OGEN N/A
- SINT 2014
- Fundamental
- Price
- OGEN $0.29
- SINT $5.31
- Analyst Decision
- OGEN
- SINT
- Analyst Count
- OGEN 0
- SINT 0
- Target Price
- OGEN N/A
- SINT N/A
- AVG Volume (30 Days)
- OGEN 14.3M
- SINT 3.9M
- Earning Date
- OGEN 03-28-2025
- SINT 03-26-2025
- Dividend Yield
- OGEN N/A
- SINT N/A
- EPS Growth
- OGEN N/A
- SINT N/A
- EPS
- OGEN N/A
- SINT N/A
- Revenue
- OGEN N/A
- SINT $3,247,000.00
- Revenue This Year
- OGEN N/A
- SINT $18.23
- Revenue Next Year
- OGEN N/A
- SINT N/A
- P/E Ratio
- OGEN N/A
- SINT N/A
- Revenue Growth
- OGEN N/A
- SINT 30.40
- 52 Week Low
- OGEN $0.25
- SINT $2.01
- 52 Week High
- OGEN $3.84
- SINT $45.60
- Technical
- Relative Strength Index (RSI)
- OGEN 46.16
- SINT 80.78
- Support Level
- OGEN $0.28
- SINT $3.98
- Resistance Level
- OGEN $0.31
- SINT $6.11
- Average True Range (ATR)
- OGEN 0.05
- SINT 0.52
- MACD
- OGEN 0.00
- SINT 0.25
- Stochastic Oscillator
- OGEN 9.39
- SINT 55.53
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.